Growth Metrics

Palisade Bio (PALI) Leases (2020 - 2025)

Palisade Bio (PALI) has disclosed Leases for 6 consecutive years, with $22000.0 as the latest value for Q2 2025.

  • On a quarterly basis, Leases fell 84.51% to $22000.0 in Q2 2025 year-over-year; TTM through Jun 2025 was $22000.0, a 84.51% decrease, with the full-year FY2024 number at $84000.0, down 57.58% from a year prior.
  • Leases was $22000.0 for Q2 2025 at Palisade Bio, down from $53000.0 in the prior quarter.
  • In the past five years, Leases ranged from a high of $363000.0 in Q2 2022 to a low of $22000.0 in Q2 2025.
  • A 5-year average of $183125.0 and a median of $182500.0 in 2021 define the central range for Leases.
  • Peak YoY movement for Leases: skyrocketed 329.69% in 2023, then plummeted 84.51% in 2025.
  • Palisade Bio's Leases stood at $153000.0 in 2021, then surged by 96.08% to $300000.0 in 2022, then tumbled by 34.0% to $198000.0 in 2023, then tumbled by 57.58% to $84000.0 in 2024, then tumbled by 73.81% to $22000.0 in 2025.
  • Per Business Quant, the three most recent readings for PALI's Leases are $22000.0 (Q2 2025), $53000.0 (Q1 2025), and $84000.0 (Q4 2024).